Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAUTIOUS: DAAs and HCC Recurrence in Chronic Hepatitis C
NCT03551444Phase 3Unknown
- Sponsor
- Ain Shams University
- Start
- Oct 2017
- Primary completion
- Apr 2019
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in hepatitis C (HCV) (2 arms), sponsored by Ain Shams University. Primary endpoint: Recurrence rate of hepatocellular carcinoma at 24 months. Status: unknown.
02
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT03551444.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03551444.